Första Crispr-terapin nu godkänd i EU

För första gången har en behandling som använder gensaxtekniken Crispr godkänts av EU-kommissionen.

Uppsalabolag riskerar avnotering – anklagas för bristande informationsgivning

Quia Pharma riskerar avnotering sedan Nasdaq påpekat vad som bedöms vara brister i informationsgivningen.

SDS rekryterar Director Business Management

SDS Life Science rekryterar Ulrika Andersson som Director Business Management. Ulrika tillträder i rollen under augusti.

Svag krona ingen nackdel för läkemedelsföretag

Läkemedels- och kemiföretag hör till vinnarna när den svenska kronan är svag, enligt en ny undersökning som bygger på intervjuer med representanter för företag.

KI’s freezer fiasco investigated: A chain of failures

A chain of combined technical and organisational shortcomings caused the freezer breakdown at the Karolinska Institute during the Christmas holidays, destroying...

Fördjupat samarbete ska stärka Göteborgs life science-kluster

Göteborg är hemvist för ett av de största hälso-klustren i Norden – men vill växa och bli ännu vassare. Nu inleder Astra Zeneca och Business Region Göteborg ett...

Mercodia AB

Investment CEO: “The Nordics are outstanding in creating successful medtech companies”

Since the beginning of last month, Susanna Francke Rodau has been a partner and the new CEO of Segulah Medical Acceleration, which invests in medical technology...

The fast route to a safe insulin pen

the pens using the Festo automation platform.

Björn Arvidsson: ”We must raise our gaze to find the answers of the future”

A system approach isn't just about understanding complexity – it's about making better decisions. By seeing ourselves as part of larger systems, we can better a...

Hon får tungt uppdrag i Astra Zeneca – ersätter frihetsberövad Kinachef

Astra Zeneca utser Iskra Reic till Executive Vice President (EVP), International. Det betyder att hon får ansvar för bolagets övergripande strategi i stora dela...

Investigations against AstraZeneca: ”Chinese interests may be behind them”

Why are there several investigations against AstraZeneca employees in China right now? Life Science Sweden continues to seek answers.

Business Sweden: “Companies have a lot to offer in data-driven precision medicine”

Data-driven precision medicine can potentially solve major healthcare problems, states Business Sweden in a new report on the subject.

Pharmaevent lockade internationella deltagare

Under tisdagen arrangerade Life Science Sweden eventet Pharma Outsourcing. I år var deltagare från över 10 länder på plats i Life City i Hagastaden.

Swedish pavilion with healthcare companies at Ukraine fair – “Ukraine is being rebuilt right now”

Private companies and public authorities are both needed in the reconstruction of Ukraine, said Minister for Health Care, Acko Ankarberg Johansson, in her openi...

Så ser investerarnas önskelista ut

Radiofarmaka, antikroppsläkemedelskonjugat och neurologi. Det är några av de hetaste områdena för investerare inom life science i Sverige just nu.

Marie Gårdmark: ”Interchangeable biological medicines – soon in a pharmacy near you?”

”Generic competition is an effective way to push down drug prices, but it has not worked equally well for biosimilars. Biosimilars require more time to gain mar...

Saving lives worldwide with low-cost molecular diagnostics

High throughput testing for many upper respiratory tract pathogens thanks to automation technology

The life science strategy – what the industry wants

are some of the points that are essential to review.

Clean solutions - Handling viscose substances with precision

Laboratories in the chemical, petrochemical, pharmaceutical and food technology industries are increasingly relying on automation for sample preparation. The Mo...

The Swedish Academy of Sciences: “We have too many researchers”

Sweden does not need more researchers, but it does need better ones. According to the Royal Swedish Academy of Sciences, funding should be distributed to favour excellence.

Biovian rekryterar från Cobra Biologics

Magnus Gustafsson blir Head of Global Business Development.

Novo Nordisk gör AI-satsning inom kardiovaskulära sjukdomar

Novo Nordisk förvärvar rättigheterna till ett flertal prekliniska program från amerikanska Valo, ett företag med expertis inom AI-driven läkemedelsutveckling.

“Don’t postpone the transition to IVDR”

Operators who have not yet started to adapt to the requirements of the new EU IVDR regulation are running out of excuses. This is the opinion of Helena Dzojic, ...